From a doctor’s standpoint, a good drug name needs to be easy to pronounce, easy to write and easy to remember. And of course, without any negative connotations. These requirements become harder to satisfy; and especially when a name should fit several different markets, linguistic difficulties multiply.
Pour les médecins, un bon nom de médicament doit être facile à prononcer, à retenir et à écrire. Il ne doit pas présenter de connotations négatives. Quand un nom doit servir plusieurs marchés, les difficultés linguistiques se multiplient.
ZANEXTRA: An anti-hypertension of a new generation, the successor of Zanidip. The objective was to underline the affiliation with the previous drug but also message the superiority of the new improved version.
GASTROWELL: An anti-diarrheal and an anti-inflammatory, two versions of the same OTC product. The name had to be simple and easily memorable for both [...]
ZANEXTRA : Un anti-hypertenseur de nouvelle génération, le successeur de Zanidip. L’impératif pour le nouveau nom : marquer cette filiation mais aussi sa supériorité par rapport au précédent médicament.
GASTROWELL : Un anti-diarrhéique et un anti-inflammatoire, deux versions du même produit de conseil. Deux mots d’ordre pour la création du nom: simplicité et appropriation facile pour les [...]
On May 12 and 13, Quensis was invited to speak at a seminar on marks and reputation, along with the French IP office, in cooperation with the Chinese IP office, SAIC. Delphine Parlier spoke to Chinese officials and industrial magnates on how Chinese corporations can best select ideal brand names that fit the global market’s cultural and legal requirements [...]
A March 2008 analysis of the database of .COM registered names shows the following share of Internet presence for each season: 74,800 domains contain SPRING (51%), 25,500 domains contain SUMMER (18%), 24,600 domains contain FALL (17%), 20,300 domain contain WINTER (14%) [...]
Many domain name disputes concern the abusive use of existing trademarks by third parties. Cybersquatters exploit the first-come, first-served principle of the domain name registration system. Initially, the Internet suffered from an absence of international legal standards for resolving these disputes [...]
Trademark law prohibits the use of a mark that is identical or similar to prior trademarks in the class or classes in question. There is, however, one exception: “diluted”marks. These are words that have been used by so many marks that the law makers finally decided that they no longer belong to anyone. What is the benefit? Simply to be able to turn to names that, while not very differentiating, are not liable to draw future lawsuits [...]
One of our clients, for a name search that required a dot-com, was concerned that our dot-com filter might eliminate a number of good potential names that are taken in dot-com but used only for domain parking. Indeed, most are for sale, generally for relatively low sums. We like challenges at Quensis, especially Guy who, in a few weeks, succeeded in building a database of more than 17million parked sites [...]
Quensis is a company specialized in name creation. Our specificity is to create names with very strong likelihood
of availability.
Quensis is based on a proprietary technology, unique in the world, which integrates the legal parameter into
the creative process and makes it possible to create names that are commercially exploitable.
Subscribe